Merck puts big data to work to solve vaccine manufacturing concern

Publicado por en 7 Abr, 2014 en Noticias | Sin comentarios

Merck puts big data to work to solve vaccine manufacturing concern

Big data analytics have become a common consideration in the R&D part of the pharmaceutical industry, allowing researchers to search and share remarkable amounts of data points. But Merck & Co. has turned to the process to solve a manufacturing problem and potentially save hundreds of millions of dollars in the process.

According to InformationWeek, the Whitehouse Station, NJ-based drugmaker was having issues with yield rates on a vaccine in 2012 and was going through the painful process of analyzing spreadsheets of process histories and other data to try to solve the problem. It meant comparing only a couple of batches at a time and was going to take a very, very long time. Jerry Megaro, Merck’s director of manufacturing advanced analytics and innovation, thought there had to be a better way and started working with a massively scalable distributed relational database. But then he learned that Merck’s R&D operation could hook him up with cloud-based Hadoop computer, which could do all the things big data analysis is known for.

Dejar una Respuesta

Tu dirección de correo electrónico no será publicada.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

Aviso de cookies